RDY
Dr. Reddy's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +22.2% ·
share flow +4.4% ·
net new positions +18.2%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 8.76M | $110.06M | n/a | −1 |
| Q2 2026 | 83 | +2 | 105.67M | $1.53B | +6 | −4 |
| Q1 2026 | 82 | +2 | 99.82M | $1.38B | +9 | −7 |
| Q4 2025 | 79 | +1 | 89.69M | $1.26B | +1 | n/a |
| Q3 2025 | 15 | +1 | 51.12M | $714.60M | +1 | n/a |
| Q2 2025 | 11 | -3 | 34.60M | $520.04M | n/a | −3 |
| Q1 2025 | 11 | +2 | 23.21M | $306.17M | +2 | n/a |
| Q4 2024 | 9 | +1 | 22.23M | $350.98M | +1 | n/a |
| Q3 2024 | 7 | -2 | 2.98M | $236.56M | +1 | −3 |
| Q2 2024 | 9 | n/a | 3.04M | $231.32M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 9.20M | -2.4% | $121.29M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 4.34M | +53.1% | $57.30M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 4.06M | -12.8% | $53.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fisher Asset Management ✦ | 2.54M | +3.0% | $33.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.01M | -14.2% | $13.32M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 648.06K | -27.7% | $8.55M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 613.21K | +4454.5% | $8.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 394.50K | New | $5.20M | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 227.12K | -31.4% | $3.00M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 159.56K | New | $2.10M | 0.0% | New | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 18.21K | -95.8% | $240,190 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $5.20M | 0.0% |
| Citadel Advisors | $2.10M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 245 holders, 116.00M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.